Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus

R. von Pelchrzim,T. Schmook,M. Friedrich,M. Worm
DOI: https://doi.org/10.1111/J.1365-4632.2004.02539.X
2006-01-01
International Journal of Dermatology
Abstract:2 Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun Rev 2003; 2: 258–263. 3 Rozo JC, Jefferies JL, Eidem BW, et al. Kawasaki disease in the adult: a case report and review of the literature. Tex Heart Inst J 2004; 31: 160–164. 4 De Vita S, Ferraccioli GF, Di Poi E, et al. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience. Clin Exp Rheumatol 1996; 14: S85–S92. 5 Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J 1999; 18: 69–70. 6 Blanchard JN, Powell HC, Freeman WR, et al. Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 2003; 36: 105–111. 7 Johnson RM, Little JR, Storch GA. Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis 2001; 32: 1628–1634.
What problem does this paper attempt to address?